Expert insights: preparing for the ongoing uncertainty around Brexit outcomes

What are the immediate and long-term impacts of Brexit on labelling, and how can medical device and pharmaceutical organisations be better prepared? Kallik’s New Business Development Manager, Richard Castle shares his thoughts:   Be better prepared for the ongoing uncertainty around Brexit outcomes. Get in touch with Richard to learn more.



Expert insights: ensuring your artwork is compliant with EU MDR

Adopting a joined-up, cloud-based labelling and artwork management solution is a key way to ensure an organisation is prepared to manage the EU MDR’s regulation and compliance changes in a more efficient manner. Bob Tilling, New Business Development Manager at Kallik provides expert insight into how adopting this solution can help you plan and prepare…


EU MDR: an opportunity or a hindrance?

With the EU MDR looming, medical device organisations have an opportunity to improve organisation-wide best practice, rather than seeing achieving compliance as a short-term business overhead. Enforced compliance such as this gives medical device organisations the chance to organise and cleanse their labelling data and in turn create downstream value now rather than later. Many…


EU MDR: preparing for the key changes

Understanding the EU MDR Europe’s medical device regulations are changing, bringing about some of the most substantial shifts to the ways in which manufacturers bring their devices into the EU market, and how compliance must be maintained throughout the product lifecycle. The regulations strive to increase the traceability and safety of medical devices in the…


Brexit – deal or no deal for labelling?

The time for the UK to leave the EU is fast approaching. With March 29th 2019 the official date. The post-Brexit transition period is in fact set to run until December 31st 2020, meaning the chances are very high that the UK-EU relationship will be staying the same until then, but two years in the…


Playing by the rules: avoiding process roadblocks with business rules

Keeping up with changing regulations Notwithstanding the upcoming implementation of the new EU MDR in May 2020, many organisations in the medical devices, pharmaceutical, chemicals and cosmetics industries are experiencing unprecedented demands from regulatory authorities and consumers alike. Product labelling must be clearer, more informative and published electronically in addition to print. It must also…


5 ways to make your supply chain more efficient

Life Sciences is a heavily regulated industry facing ever-changing regulation and legislation. It is increasingly important therefore, to ensure your organisation puts the necessary processes in place in order to remain compliant when it comes to labelling. Improving the efficiency of labelling and artwork processes across your supply chain is one way to do this….


A strategic, enterprise-wide approach to labelling: how can your medical device organisation benefit?

Global medical device companies are increasingly looking at labelling from a strategic perspective. They have recognised that accurate labelling is critical for maintaining compliance, ensuring brand consistency and improving operational efficiency, with all three helping to support business growth. To work as efficiently as possible, labelling needs to be integrated into an enterprise business process,…


Labelling digitalisation – the importance of consistency

When it comes to the medical devices supply chain, it can often seem to be made up of a series of isolated steps from product development through to the patient or healthcare provider. Labelling digitalisation across the supply chain therefore, can help build a more integrated, fully transparent supply chain for all involved in the…